Helen Fox

2.5k total citations
26 papers, 1.9k citations indexed

About

Helen Fox is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Helen Fox has authored 26 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 12 papers in Cardiology and Cardiovascular Medicine and 7 papers in Physiology. Recurrent topics in Helen Fox's work include Viral gastroenteritis research and epidemiology (12 papers), Viral Infections and Immunology Research (12 papers) and Asthma and respiratory diseases (7 papers). Helen Fox is often cited by papers focused on Viral gastroenteritis research and epidemiology (12 papers), Viral Infections and Immunology Research (12 papers) and Asthma and respiratory diseases (7 papers). Helen Fox collaborates with scholars based in United Kingdom, United States and France. Helen Fox's co-authors include Martin Blogg, Jean Bousquet, S. Hedgecock, Stephen T. Holgate, Giovanni Della Cioppa, Marc Humbert, G. Ayre, Kian Fan Chung, A M Vignola and K. Surrey and has published in prestigious journals such as The Lancet, Nature Communications and Gut.

In The Last Decade

Helen Fox

22 papers receiving 1.8k citations

Peers

Helen Fox
Gerald J. Gleich United States
Bruno Detry Belgium
K M Leiferman United States
Jane M. Schuh United States
Ali Yalçindağ United States
M Capron France
Husein Hadeiba United States
Sabine Charron France
Erik Wambre United States
James E. Norton United States
Gerald J. Gleich United States
Helen Fox
Citations per year, relative to Helen Fox Helen Fox (= 1×) peers Gerald J. Gleich

Countries citing papers authored by Helen Fox

Since Specialization
Citations

This map shows the geographic impact of Helen Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Fox more than expected).

Fields of papers citing papers by Helen Fox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Fox. The network helps show where Helen Fox may publish in the future.

Co-authorship network of co-authors of Helen Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Fox. A scholar is included among the top collaborators of Helen Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Fox. Helen Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sherry, Lee, Keith Grehan, Mohammad W. Bahar, et al.. (2025). Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation. npj Vaccines. 10(1). 64–64.
2.
Martyna, Agnieszka, Keith Grehan, Helen Fox, et al.. (2023). Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidate. Journal of General Virology. 104(6). 9 indexed citations
3.
Bahar, Mohammad W., Veronica Nasta, Helen Fox, et al.. (2022). A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation. Communications Biology. 5(1). 1293–1293. 5 indexed citations
4.
Alnaji, Fadi G., Kirsten Bentley, Andrew Woodman, et al.. (2022). Generated Randomly and Selected Functionally? The Nature of Enterovirus Recombination. Viruses. 14(5). 916–916. 7 indexed citations
5.
Fox, Helen, et al.. (2022). Thermal stabilization of enterovirus A 71 and production of antigenically stabilized empty capsids. Journal of General Virology. 103(8). 4 indexed citations
6.
Bahar, Mohammad W., Claudine Porta, Helen Fox, et al.. (2021). Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccines. npj Vaccines. 6(1). 5–5. 28 indexed citations
7.
Farcet, Maria R., Jens Modrof, Andreas Schirmer, et al.. (2018). Continued use of poliovirus after eradication: hyper‐attenuated strains as a safe alternative for release testing of human immunoglobulins. Transfusion. 58(S3). 3084–3089. 5 indexed citations
8.
Marsian, Johanna, Helen Fox, Mohammad W. Bahar, et al.. (2017). Plant-made polio type 3 stabilized VLPs—a candidate synthetic polio vaccine. Nature Communications. 8(1). 245–245. 87 indexed citations
9.
Fox, Helen, et al.. (2017). Genetically Thermo-Stabilised, Immunogenic Poliovirus Empty Capsids; a Strategy for Non-replicating Vaccines. PLoS Pathogens. 13(1). e1006117–e1006117. 39 indexed citations
10.
Fox, Helen, et al.. (2015). New Strains Intended for the Production of Inactivated Polio Vaccine at Low-Containment After Eradication. PLoS Pathogens. 11(12). e1005316–e1005316. 26 indexed citations
11.
Bousquet, Jean, Klaus F. Rabe, Marc Humbert, et al.. (2007). Predicting and evaluating response to omalizumab in patients with severe allergic asthma. Respiratory Medicine. 101(7). 1483–1492. 231 indexed citations
12.
Busse, William W., Helen Fox, K. Surrey, Robert Maykut, & Colin Reisner. (2006). Clinically Relevant Improvements in Asthma-Related Quality of Life in Patients Receiving Omalizumab as Add-On Therapy. Journal of Allergy and Clinical Immunology. 117(2). S8–S8. 1 indexed citations
13.
Chipps, Bradley E., Jonathan Corren, Adam Finn, et al.. (2005). Omalizumab significantly improves quality of life in patients with severe persistent asthma. Journal of Allergy and Clinical Immunology. 115(2). S5–S5. 7 indexed citations
14.
Holgate, Stephen T., А. Г. Чучалин, Jean‐Louis Hébert, et al.. (2004). Efficacy and safety of a recombinant anti‐immunoglobulin E antibody (omalizumab) in severe allergic asthma. Clinical & Experimental Allergy. 34(4). 632–638. 406 indexed citations
15.
Vignola, A M, Marc Humbert, Jean Bousquet, et al.. (2004). Efficacy and tolerability of anti‐immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR. Allergy. 59(7). 709–717. 309 indexed citations
16.
Ayres, Jon G., Bernard Higgins, Edwin R. Chilvers, et al.. (2004). Efficacy and tolerability of anti‐immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate‐to‐severe) allergic asthma. Allergy. 59(7). 701–708. 225 indexed citations
17.
Bousquet, Jean, Pedro Cabrera, Neville Berkman, et al.. (2004). The effect of treatment with omalizumab, an anti‐IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy. 60(3). 302–308. 312 indexed citations
18.
Fox, Helen, P. Legmann, & Marie‐Hélène Lévesque. (1985). [Colorectal complications of radiological examinations].. PubMed. 21(6). 377–81.
19.
Mani, V, et al.. (1976). TREATMENT OF ULCERATIVE COLITIS WITH ORAL DISODIUM CROMOGLYCATE. The Lancet. 307(7957). 439–441. 52 indexed citations
20.
Fh, Green & Helen Fox. (1973). An immunofluorescence study of the intestinal mucosa in ulcerative colitis and Crohn's disease.. PubMed. 110(3). Pii–Pii. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerald J. Gleich Breakdown of academic impact, for papers by Bruno Detry Breakdown of academic impact, for papers by K M Leiferman Breakdown of academic impact, for papers by Jane M. Schuh Breakdown of academic impact, for papers by Ali Yalçindağ Breakdown of academic impact, for papers by M Capron Breakdown of academic impact, for papers by Husein Hadeiba Breakdown of academic impact, for papers by Sabine Charron Breakdown of academic impact, for papers by Erik Wambre Breakdown of academic impact, for papers by James E. Norton
Rankless by CCL
2026